Cogent Biosciences, Inc. SEC filings COGT
Cogent Biosciences, Inc. has 616 filings in SEC EDGAR's recent list, going back to Oct 20, 2014. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 2, 2026 | Sep 1, 2026 |
| 8-K |
Current report
Other events
|
Aug 10, 2026 | Aug 10, 2026 |
| 424B5 | Prospectus supplement | Aug 10, 2026 | — |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2026 | Jun 9, 2026 |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
| ARS | Annual report to shareholders | Apr 23, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 23, 2026 | — |
| DEF 14A | Proxy statement | Apr 23, 2026 | Jun 9, 2026 |
| S-8 | Employee stock plan registration | Feb 17, 2026 | — |
| 10-K | Annual report | Feb 17, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 17, 2026 | Feb 17, 2026 |
| 8-K |
Current report
Other events
|
Dec 8, 2025 | Dec 6, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Nov 18, 2025 | Nov 18, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 13, 2025 | Nov 11, 2025 |
| 424B5 | Prospectus supplement | Nov 12, 2025 | — |
| 424B5 | Prospectus supplement | Nov 12, 2025 | — |
| FWP | Free writing prospectus | Nov 12, 2025 | — |
| 424B5 | Prospectus supplement | Nov 12, 2025 | — |
| 424B5 | Prospectus supplement | Nov 12, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 10, 2025 | Nov 10, 2025 |
| S-3ASR | Automatic shelf registration | Nov 7, 2025 | — |
| 10-Q | Quarterly report | Nov 7, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2025 | Nov 3, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Sep 11, 2025 | Sep 5, 2025 |
| 10-Q | Quarterly report | Aug 5, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Material agreement, Results of operations
|
Jul 10, 2025 | Jul 7, 2025 |
| 424B5 | Prospectus supplement | Jul 9, 2025 | — |
| 424B5 | Prospectus supplement | Jul 8, 2025 | — |
| 8-K |
Current report
Other events
|
Jul 7, 2025 | Jul 7, 2025 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Jun 11, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
|
Jun 5, 2025 | Jun 4, 2025 |
| EFFECT | Filing | May 9, 2025 | — |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| 424B5 | Prospectus supplement | May 6, 2025 | — |
| POS AM | Filing | May 6, 2025 | — |
| ARS | Annual report to shareholders | Apr 22, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 22, 2025 | — |
| DEF 14A | Proxy statement | Apr 22, 2025 | Jun 4, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 11, 2025 | Jun 4, 2025 |
| S-8 | Employee stock plan registration | Feb 25, 2025 | — |
| 10-K | Annual report | Feb 25, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2025 | Feb 25, 2025 |
| 8-K |
Current report
Other events
|
Dec 9, 2024 | Dec 8, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Other events
|
Sep 3, 2024 | Sep 3, 2024 |
| S-8 | Employee stock plan registration | Aug 6, 2024 | — |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Other events
|
Jun 27, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 5, 2024 | Jun 5, 2024 |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 7, 2024 | May 7, 2024 |
| ARS | Annual report to shareholders | Apr 23, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 23, 2024 | — |
| DEF 14A | Proxy statement | Apr 23, 2024 | Jun 5, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 12, 2024 | Jun 5, 2024 |
| EFFECT | Filing | Apr 10, 2024 | — |
| CORRESP | Letter to the SEC | Apr 8, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 5, 2024 | — |
| S-3 | Shelf registration | Mar 29, 2024 | — |
| 8-K |
Current report
Unregistered share sale, Bylaw or fiscal year change
|
Mar 22, 2024 | Mar 21, 2024 |
| S-8 | Employee stock plan registration | Feb 26, 2024 | — |
| 10-K | Annual report | Feb 26, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2024 | Feb 26, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Regulation FD disclosure
|
Feb 14, 2024 | Feb 13, 2024 |
| 8-K |
Current report
Other events
|
Dec 11, 2023 | Dec 9, 2023 |
| 10-Q | Quarterly report | Nov 7, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2023 | Nov 2, 2023 |
| S-8 | Employee stock plan registration | Aug 8, 2023 | — |
| 10-Q | Quarterly report | Aug 8, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Material agreement
|
Jun 8, 2023 | Jun 6, 2023 |
| 424B5 | Prospectus supplement | Jun 8, 2023 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 7, 2023 | Jun 7, 2023 |
| 424B5 | Prospectus supplement | Jun 6, 2023 | — |
| 8-K |
Current report
Other events
|
Jun 6, 2023 | Jun 3, 2023 |
| 10-Q | Quarterly report | May 9, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 9, 2023 | May 9, 2023 |
| ARS | Annual report to shareholders | Apr 25, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 25, 2023 | — |
| DEF 14A | Proxy statement | Apr 25, 2023 | Jun 7, 2023 |
| S-8 | Employee stock plan registration | Mar 14, 2023 | — |
| 10-K | Annual report | Mar 14, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 14, 2023 | Mar 14, 2023 |
| S-3ASR | Automatic shelf registration | Feb 10, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 12, 2022 | Dec 11, 2022 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2022 | Nov 14, 2022 |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K/A |
Amended current report
Material agreement, Other events
|
Jun 16, 2022 | Jun 13, 2022 |
| 8-K |
Current report
Material agreement
|
Jun 15, 2022 | Jun 13, 2022 |
| 424B5 | Prospectus supplement | Jun 15, 2022 | — |
| FWP | Free writing prospectus | Jun 14, 2022 | — |
| 424B5 | Prospectus supplement | Jun 13, 2022 | — |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 10, 2022 | Jun 7, 2022 |
| EFFECT | Filing | May 24, 2022 | — |
| CORRESP | Letter to the SEC | May 20, 2022 | — |
| UPLOAD | Letter from the SEC | May 17, 2022 | — |
| EFFECT | Filing | May 13, 2022 | — |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 10, 2022 | May 10, 2022 |
| S-3 | Shelf registration | May 6, 2022 | — |
| POS AM | Filing | May 6, 2022 | — |
| 8-K |
Current report
Agreement ended
|
May 6, 2022 | May 5, 2022 |
| DEFA14A | Additional proxy material | Apr 26, 2022 | — |
| DEF 14A | Proxy statement | Apr 26, 2022 | Jun 7, 2022 |
| S-8 | Employee stock plan registration | Mar 17, 2022 | — |
| 10-K | Annual report | Mar 15, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 15, 2022 | Mar 15, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 27, 2021 | Dec 24, 2021 |
| 10-Q | Quarterly report | Nov 10, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| S-8 | Employee stock plan registration | Aug 17, 2021 | — |
| 10-Q | Quarterly report | Aug 16, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 16, 2021 | Aug 16, 2021 |
| 8-K |
Current report
Material agreement
|
Jul 9, 2021 | Jul 6, 2021 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 17, 2021 | Jun 16, 2021 |
| 10-Q | Quarterly report | May 12, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 12, 2021 | May 12, 2021 |
| DEFA14A | Additional proxy material | Apr 30, 2021 | — |
| DEF 14A | Proxy statement | Apr 30, 2021 | Jun 16, 2021 |
| SEC STAFF LETTER | Filing | Mar 31, 2021 | — |
| EFFECT | Filing | Mar 18, 2021 | — |
| CORRESP | Letter to the SEC | Mar 16, 2021 | — |
| S-8 | Employee stock plan registration | Mar 16, 2021 | — |
| 10-K | Annual report | Mar 16, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2021 | Mar 16, 2021 |
| SEC STAFF LETTER | Filing | Mar 3, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Feb 22, 2021 | Feb 22, 2021 |
| UPLOAD | Letter from the SEC | Feb 12, 2021 | — |
| S-3 | Shelf registration | Feb 9, 2021 | — |
| 8-K |
Current report
Material agreement, Other events
|
Dec 2, 2020 | Dec 1, 2020 |
| 424B5 | Prospectus supplement | Dec 2, 2020 | — |
| 424B3 | Prospectus | Dec 2, 2020 | — |
| 424B5 | Prospectus supplement | Nov 30, 2020 | — |
| 8-K |
Current report
Other events
|
Nov 30, 2020 | Nov 30, 2020 |
| 10-Q | Quarterly report | Nov 9, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations, Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
Nov 9, 2020 | Nov 6, 2020 |
| S-8 | Employee stock plan registration | Nov 5, 2020 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 26, 2020 | Oct 22, 2020 |
| 8-K |
Current report
Officer or director change
|
Oct 23, 2020 | Oct 19, 2020 |
| EFFECT | Filing | Oct 15, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 13, 2020 | — |
| CORRESP | Letter to the SEC | Oct 13, 2020 | — |
| DEFM14A | Filing | Oct 9, 2020 | — |
| CORRESP | Letter to the SEC | Oct 6, 2020 | — |
| PRER14A | Filing | Oct 6, 2020 | — |
| 10-Q/A | Amended quarterly report | Oct 6, 2020 | Jun 30, 2020 |
| UPLOAD | Letter from the SEC | Oct 6, 2020 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure
|
Oct 5, 2020 | Oct 2, 2020 |
| CORRESP | Letter to the SEC | Oct 2, 2020 | — |
| PRER14A | Filing | Oct 2, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 30, 2020 | — |
| S-3 | Shelf registration | Sep 22, 2020 | — |
| CORRESP | Letter to the SEC | Sep 22, 2020 | — |
| PRER14A | Filing | Sep 22, 2020 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
|
Sep 3, 2020 | Aug 28, 2020 |
| UPLOAD | Letter from the SEC | Aug 25, 2020 | — |
| CORRESP | Letter to the SEC | Aug 19, 2020 | — |
| PRER14A | Filing | Aug 19, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 12, 2020 | — |
| 10-Q | Quarterly report | Aug 11, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2020 | Aug 11, 2020 |
| 8-K |
Current report
Material agreement
|
Aug 10, 2020 | Aug 6, 2020 |
| PRE 14A | Preliminary proxy statement | Jul 30, 2020 | Jul 29, 2020 |
| D | Filing | Jul 21, 2020 | — |
| D | Filing | Jul 21, 2020 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Jul 6, 2020 | Jul 5, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2020 | Jun 9, 2020 |
| 8-K |
Current report
Officer or director change
|
May 15, 2020 | May 14, 2020 |
| SC TO-I/A | Filing | May 11, 2020 | — |
| 10-Q | Quarterly report | May 11, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations, Other events
|
May 11, 2020 | May 7, 2020 |
| DEF 14A | Proxy statement | Apr 29, 2020 | Jun 9, 2020 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2020 | Jun 9, 2020 |
| SC TO-I | Filing | Apr 8, 2020 | — |
| S-8 | Employee stock plan registration | Mar 26, 2020 | — |
| 10-K | Annual report | Mar 26, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 26, 2020 | Mar 26, 2020 |
| 424B5 | Prospectus supplement | Mar 20, 2020 | — |
| 8-K |
Current report
Material agreement, Other events
|
Mar 20, 2020 | Mar 19, 2020 |
| 8-K |
Current report
Other events
|
Mar 16, 2020 | Mar 13, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Mar 10, 2020 | Mar 9, 2020 |
| 8-K |
Current report
Other events
|
Mar 9, 2020 | Mar 4, 2020 |
| 8-K |
Current report
Exit or restructuring costs, Other events
|
Mar 2, 2020 | Mar 2, 2020 |
| DEF 14A | Proxy statement | Feb 18, 2020 | Mar 9, 2020 |
| PRE 14A | Preliminary proxy statement | Feb 7, 2020 | Feb 7, 2020 |
| 8-K |
Current report
Other events
|
Jan 29, 2020 | Jan 29, 2020 |
| 8-K |
Current report
Agreement ended
|
Jan 17, 2020 | Jan 16, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2020 | Jan 13, 2020 |
| 8-K |
Current report
Listing notice
|
Jan 6, 2020 | Dec 31, 2019 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- COGT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Waltham, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1622229
- Former names
- Unum Therapeutics Inc. (until Oct 5, 2020); Unum Therapeutics, Inc. (until Mar 30, 2018)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.